• Presentation
• CV
• Research outputs
• Prizes
• Activities
• Keywords
• Most downloaded

Main areas of interest include the physiology and pathophysiology of energy and substrate metabolism, with special emphasis on the etiology and treatment of obesity. 

• Knight of the Order of Dannebrog 1999.
• Knight of the First Order of Dannebrog 2012.
• Current citation H-index: 86. Thomson Reuters Science Index 2010: 5th for obesity publications
• Academic honours include Servier's Award for Outstanding Obesity Research 1990
• IASO André Mayer Award 1994
• Danone Chair in Nutrition 2002 at The University of Antwerp
• LIFE Communication Prize 2007
• International Association of Business Communicators’ EME Excel Merit Award for Communication Leadership 2009
• LIFE Innovations Award 2010
• Nutrition & Santé Weight Management Award (France) 2010
• Finnish Association of Internal Medicine Esko Nikkilä Prize 2012
• American Society for Nutrition Robert H. Herman Award 2012
• Danish Communication Association KomPris' 12 to the OPUS Research Center 2012
• International Association for the Study of Obesity Willendorf Award 2014

Primary fields of research

Major current research is focused on the role of dietary macronutrients and glycemic index for body weight regulation, and the hormonal mediation of hunger and satiety by gastrointestinal peptides such as GLP-1, PYY, CCK etc.. In addition, I head the OPUS Centre, 'Optimal well-being, development and health for Danish children through a healthy New Nordic Diet’, which ran from 2009 until 2014. The main objective is to develop a healthy and palatable new food and eating concept, and to examine how such a diet can affect mental and physical health in a Nordic population. http://www.foodoflife.dk/Opus/English.aspx. Other active research includes studies of the role of dairy and bio-active food ingredients (various specific fibres) in aspects of human health and testing of pharmaceutical compounds for the treatment of obesity.

Possible conflicts of interest

• Member of the Board, UCPH strategic platform for Lifestyle, Obesity and Metabolic research (UCPH LOM) (2013-)
• Member of the Board, Christian d. IX og Dronning Louises Jubilæumslegat (King Christian IX and Queen Louise's Jubilee Foundation) (2015-)
• Salaried Associate Editor of American Journal of Clinical Nutrition (2011-)
• Currently consultant or member of advisory boards for a number companies, including: Acino, Switzerland; BioCare Copenhagen, DK; Dutch Beer Institute, NL; Gelesis, USA; Groupe Éthique et Santé, France; McCain Foods Limited, USA; Navamedic, DK; Novo Nordisk, DK; Pfizer, USA; Saniona, DK; Weight Watchers, USA; Zaluvida, Switzerland.
• Editorial Boards: Arbor Clinical Nutrition Updates; Recent Patents on Endocrinology & Metabolism Drug Discovery, benthamscience.com; Cerrahpasa Medical Reviews /University of Istanbul Medical Journal; Annals of Nutrition and Metabolism; Journal of Obesity and Metabolic Research; Obesity Medicine.
• Membership of extra mural academic committee International Carbohydrate Quality Consortium (ICQC) group, University of Toronto, Canada.
• Recipient of honoraria as speaker for a wide range of Danish and international concerns. 
• Co-inventor of a number of patents owned, in accordance with Danish University regulations, by the University of Copenhagen.
• Co-owner (2005-) of the Danish consultancy company Dentacom.
• Co-founder (2005) and co-owner of the University of Copenhagen spin-out company Mobile Fitness A/S, Denmark.
• Co-founder (2014), co-owner and member of the Executive Board of the University of Copenhagen spin-out company Flaxslim ApS, Denmark.
• Co-owner (2017) of the University of Copenhagen spin-out company Personalized Weight Management Research Consortium ApS (Gluco-diet.dk).
• Recipient of stock options in Gelesis, USA, 2018.
• Arne Astrup is not advocate or activist for specific diets, and is not strongly committed to any specific diet, e.g. veganism, Atkins diet, gluten-free diet, high animal protein diet, or dietary supplements.

Selected publications

1. Published

   What went in when trans went out?

   Stender, S., Astrup, A. & Dyerberg, J., 2009, In : New England Journal of Medicine. 361, 3, p. 314-316 3 p.

   Research output: Contribution to journal › Journal article › Research › peer-review

2. Published

   Weight loss produced by gastric bypass surgery: more gut feelings hit the brain

   Astrup, A., 2012, In : American Journal of Clinical Nutrition. 96, 3, p. 457-458 2 p.

   Research output: Contribution to journal › Editorial › Research

3. Published

   Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial

   Jensen, M. M. G., Kristensen, M. & Astrup, A., 2012, In : American Journal of Clinical Nutrition. 96, 1, p. 5-13 9 p.

   Research output: Contribution to journal › Journal article › Research › peer-review

4. Published

   Diets with high or low protein content and glycemic index for weight-loss maintenance

   Larsen, T. M., Dalskov, S-M., Baak, M. V., Jebb, S. A., Papadaki, A., Pfeiffer, A. F. H., Martinez, J. A., Handjieva-Darlenska, T., Kunesová, M., Pihlsgård, M., Stender, S., Holst, C., Saris, W. H. M. & Astrup, A., 2010, In : New England Journal of Medicine. 363, 22, p. 2102-2113 12 p.

   Research output: Contribution to journal › Journal article › Research › peer-review

5. Published

   High levels of industrially produced trans fat in popular fast foods

   Stender, S., Dyerberg, J. & Astrup, A., 2006, In : New England Journal of Medicine. 354, 15, p. 1650-1652 3 p.

   Research output: Contribution to journal › Journal article › Research › peer-review

6. Published

   Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

   Astrup, A., Rössner, S., Gaal, L. V., Rissanen, A., Niskanen, L., Hakim, M. A., Madsen, J., Rasmussen, M. F., Lean, M. E. J. & NN8022-1807 Study Group, 2009, In : Lancet. 374, 9701, p. 1606-1616 11 p.

   Research output: Contribution to journal › Journal article › Research › peer-review

7. Published

   Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

   Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H. & Astrup, A., 2007, In : Lancet. 370, 9600, p. 1706-1713 8 p.

   Research output: Contribution to journal › Journal article › Research › peer-review

8. Published

   Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss?

   Astrup, A., Larsen, T. M. & Harper, A., 2004, In : Lancet. 364, p. 897-899 3 p.

   Research output: Contribution to journal › Journal article › Research › peer-review

9. Published

   Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

   Astrup, A., Madsbad, S., Breum, L., Jensen, T. J., Kroustrup, J. P. & Larsen, T. M., 2008, In : Lancet. 372, 9653, p. 1906-1913 8 p.

   Research output: Contribution to journal › Journal article › Research › peer-review